Krsnaa Diagnostics Limited (KRSNAA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Based on the latest financial reports, Krsnaa Diagnostics Limited (KRSNAA) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs518.74 Million ≈ $5.61 Million USD) by net assets (Rs9.23 Billion ≈ $99.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KRSNAA net asset quality index to measure how much of total assets are equity-financed.

Krsnaa Diagnostics Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Krsnaa Diagnostics Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Krsnaa Diagnostics Limited cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Krsnaa Diagnostics Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Krsnaa Diagnostics Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Anika Therapeutics Inc NASDAQ:ANIK	-0.036x
Franklin Universal Closed Fund NYSE:FT	0.027x
Acme Electronics TWO:8121	0.015x
Oriental Interest Bhd KLSE:5827	0.004x
Solid FAB ST:SFAB	0.092x
SEG International Bhd KLSE:9792	0.429x
Shanghai Jinqiao Export Processing Zone Development Co Ltd B SHG:900911	-0.111x
Nexen Corporation KO:005720	0.031x

Annual Cash Flow Conversion Efficiency for Krsnaa Diagnostics Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Krsnaa Diagnostics Limited from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Krsnaa Diagnostics Limited stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs8.83 Billion ≈ $95.47 Million	Rs873.27 Million ≈ $9.44 Million	0.099x	+229.06%
2024-03-31	Rs8.10 Billion ≈ $87.58 Million	Rs243.45 Million ≈ $2.63 Million	0.030x	-70.89%
2023-03-31	Rs7.39 Billion ≈ $79.89 Million	Rs763.01 Million ≈ $8.25 Million	0.103x	-46.22%
2022-03-31	Rs6.69 Billion ≈ $72.32 Million	Rs1.28 Billion ≈ $13.89 Million	0.192x	-56.58%
2021-03-31	Rs2.32 Billion ≈ $25.08 Million	Rs1.03 Billion ≈ $11.09 Million	0.442x	+330.44%
2020-03-31	Rs-1.97 Billion ≈ $-21.30 Million	Rs378.09 Million ≈ $4.09 Million	-0.192x	+72.02%
2019-03-31	Rs-849.21 Million ≈ $-9.18 Million	Rs582.66 Million ≈ $6.30 Million	-0.686x	+52.08%
2018-03-31	Rs-228.96 Million ≈ $-2.48 Million	Rs327.85 Million ≈ $3.55 Million	-1.432x	-274.29%
2017-03-31	Rs757.06 Million ≈ $8.19 Million	Rs621.99 Million ≈ $6.73 Million	0.822x	--

About Krsnaa Diagnostics Limited

NSE:KRSNAA India Diagnostics & Research

Market Cap

$196.42 Million

Rs18.16 Billion INR

Market Cap Rank

#16617 Global

#870 in India

Share Price

Rs559.90

Change (1 day)

-0.28%

52-Week Range

Rs520.30 - Rs867.05

All Time High

Rs1020.15